Avanos Medical has agreed to be acquired by affiliates of American Industrial Partners in an all-cash deal valued at about $1.272 billion.
Avanos stockholders will receive $25.00 per share, a 72.1% premium to the company’s April 13 closing price and an 82.8% premium to its 30-day volume-weighted average price through that date.
The deal was unanimously approved by Avanos’ board and is expected to close in the second half of 2026. Once completed, Avanos will become a private company and its shares will no longer trade on the New York Stock Exchange.
The company also said it has postponed its 2026 annual meeting, which had been scheduled for April 21, 2026.
Avanos will remain headquartered in Alpharetta, Georgia. Today the company's shares have moved 0.36% to a price of $13.85. For more information, read the company's full 8-K submission here.
